Font Size:
a
A
A
Keyword [nucleos(t)ide]
Result: 101 - 113 | Page: 6 of 6
101.
Effects Of Hepatitis B Core-relative Antigen And T Cell Receptor Dynamic Changes On Relapse After Discontinuation Of Nucleos(t)ide Analogues Treatment In Chronic Hepatitis B Patients
102.
Serum Hepatitis B Virus RNA Levels Predict The Curative Effect In Chronic Hepatitis B Patients With High Viral Load Treated With Nucleos(t)ide Analogue
103.
A Clinical-Effectiveness Study Of Add-On Pegylated Interferon Alfa Therapy In Nucleos(t)ide Analogues Treated HBeAg Negative Chronic Hepatitis B Patients
104.
Clinical Characteristics Of Patients With Hepatitis B Associated Primary Liver Cancer With Low Viral Load
105.
Impact Of Nucleos(t)ide Analogues Therapy On The Metabolic Parameters Of Patients With Chronic Hepatitis B
106.
Clinical Study Of Entecavir In Patients With Chronic Hepatitis B With Low-level Viremia
107.
Influencing Factors For The Partial Virological Response Of Chronic Hepatitis B Patients Treated With Nucleos(t)ide Analogs
108.
Clinical Study Of Nucleos(t)ide Analogues In The Treatment Of Patients With Chronic HBV Infection With Normal ALT
109.
Changes And Clinical Significance Of HBV RNA Quantification In Chronic Hepatitis B Patients Treated With NAs
110.
The Value Of Serum Anti-HBc Quantification In The Natural Course And Treatment Monitoring Of Patients With Chronic HBV Infection
111.
Cross-sectional Study Of The Middle-aged And Elderly Hepatitis B Cirrhosis Combined Renal Damage
112.
Clinical Efficacy Analysis And Prediction Of Pegylated Interferon In Nucleoside Analogue Experienced Negative HBeAg Chronic Hepatitis B
113.
Response Prediction After The Addition Of Pegylated Interferon Therapy For 48 Weeks In Chronic Hepatitis B Patients With Low-Level HBsAg Previously Treated With Nucleos(t)ide Analogues
<<First
<Prev
Next>
Last>>
Jump to